Contrasting Nyxoah (NASDAQ:NYXH) and SS Innovations International (NASDAQ:SSII)

SS Innovations International (NASDAQ:SSII) and Nyxoah (NASDAQ:NYXH) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends.

Valuation and Earnings

This table compares SS Innovations International and Nyxoah”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49 million	16.08	-$12.13 million	($0.06)	-56.83
Nyxoah	$21.66 million	2.90	-$101.92 million	($2.52)	-0.64

SS Innovations International has higher revenue and earnings than Nyxoah. SS Innovations International is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

SS Innovations International has a beta of -1.94, meaning that its stock price is 294% less volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500.

Profitability

This table compares SS Innovations International and Nyxoah’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-23.73%	-26.77%	-15.01%
Nyxoah	-443.16%	-178.90%	-81.83%

Analyst Ratings

This is a breakdown of recent ratings and target prices for SS Innovations International and Nyxoah, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1	0	0	0	1.00
Nyxoah	1	1	2	0	2.25

SS Innovations International presently has a consensus price target of $7.00, indicating a potential upside of 105.28%. Nyxoah has a consensus price target of $4.26, indicating a potential upside of 163.09%. Given Nyxoah’s stronger consensus rating and higher probable upside, analysts plainly believe Nyxoah is more favorable than SS Innovations International.

Summary

SS Innovations International beats Nyxoah on 7 of the 12 factors compared between the two stocks.

About SS Innovations International

AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.